BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 30515564)

  • 21. Treatment of patients with stage I focal anaplastic and diffuse anaplastic Wilms tumour: A report from the SIOP-WT-2001 GPOH and UK-CCLG studies.
    Mifsud W; Furtwängler R; Vokuhl C; D'Hooghe E; Pritchard-Jones K; Graf N; Vujanić GM
    Eur J Cancer; 2022 May; 166():1-7. PubMed ID: 35255331
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anaplasia in unilateral Wilms' tumor: a report from the National Wilms' Tumor Study Pathology Center.
    Zuppan CW; Beckwith JB; Luckey DW
    Hum Pathol; 1988 Oct; 19(10):1199-209. PubMed ID: 2844645
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical characteristics and outcomes of children with WAGR syndrome and Wilms tumor and/or nephroblastomatosis: The 30-year SIOP-RTSG experience.
    Hol JA; Jongmans MCJ; Sudour-Bonnange H; Ramírez-Villar GL; Chowdhury T; Rechnitzer C; Pal N; Schleiermacher G; Karow A; Kuiper RP; de Camargo B; Avcin S; Redzic D; Wachtel A; Segers H; Vujanic GM; van Tinteren H; Bergeron C; Pritchard-Jones K; Graf N; van den Heuvel-Eibrink MM;
    Cancer; 2021 Feb; 127(4):628-638. PubMed ID: 33146894
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Wilms' tumour of unfavorable histology--results of treatment with the SIOP 93-01 protocol at the Gdańsk centre. Preliminary report].
    Stefanowicz J; Sierota D; Balcerska A; Stoba C
    Med Wieku Rozwoj; 2004; 8(2 Pt 1):197-200. PubMed ID: 15738594
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Results of the United Kingdom Children's Cancer Study Group first Wilms' Tumor Study.
    Pritchard J; Imeson J; Barnes J; Cotterill S; Gough D; Marsden HB; Morris-Jones P; Pearson D
    J Clin Oncol; 1995 Jan; 13(1):124-33. PubMed ID: 7799012
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Botryoid Wilms' tumor of the renal pelvis.
    Weinberg AG; Currarino G; Hurt GE
    Arch Pathol Lab Med; 1984 Feb; 108(2):147-8. PubMed ID: 6320758
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Optimal duration of preoperative therapy in unilateral and nonmetastatic Wilms' tumor in children older than 6 months: results of the Ninth International Society of Pediatric Oncology Wilms' Tumor Trial and Study.
    Tournade MF; Com-Nougué C; de Kraker J; Ludwig R; Rey A; Burgers JM; Sandstedt B; Godzinski J; Carli M; Potter R; Zucker JM;
    J Clin Oncol; 2001 Jan; 19(2):488-500. PubMed ID: 11208843
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Age is not a prognostic factor in children with Wilms tumor beyond stage I in Africa.
    Aronson DC; Hadley GP
    Pediatr Blood Cancer; 2014 Jun; 61(6):987-9. PubMed ID: 24453084
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anaplastic histology Wilms' tumors registered to the Japan Wilms' Tumor Study Group are less aggressive than that in the National Wilms' Tumor Study 5.
    Oue T; Koshinaga T; Takimoto T; Okita H; Tanaka Y; Nozaki M; Haruta M; Kaneko Y; Fukuzawa M;
    Pediatr Surg Int; 2016 Sep; 32(9):851-5. PubMed ID: 27473009
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Improved survival of children with wilms tumor.
    Kutluk T; Varan A; Büyükpamukçu N; Atahan L; Cağlar M; Akyüz C; Büyükpamukçu M
    J Pediatr Hematol Oncol; 2006 Jul; 28(7):423-6. PubMed ID: 16825987
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Wilms' tumor in adults: results of the Society of Pediatric Oncology (SIOP) 93-01/Society for Pediatric Oncology and Hematology (GPOH) Study.
    Reinhard H; Aliani S; Ruebe C; Stöckle M; Leuschner I; Graf N
    J Clin Oncol; 2004 Nov; 22(22):4500-6. PubMed ID: 15542800
    [TBL] [Abstract][Full Text] [Related]  

  • 32. "Teratoid" Wilms Tumor: The Extreme End of Heterologous Element Differentiation, Not a Separate Entity.
    D'Hooghe E; Mifsud W; Vujanić GM
    Am J Surg Pathol; 2019 Nov; 43(11):1583-1590. PubMed ID: 31600178
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Preoperative Wilms tumor rupture in children.
    Zhang Y; Song HC; Yang YF; Sun N; Zhang WP; Huang CR
    Int Urol Nephrol; 2021 Apr; 53(4):619-625. PubMed ID: 33245535
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analysis of prognostic factors of nephroblastoma in a Tunisian cohort.
    Doghri R; Aloui A; Berrazaga Y; Boujelbene N; Driss M; Abess I; Fdhila F; Charfi L; Mezlini A; Mrad K
    Tunis Med; 2018 Mar; 96(3):193-202. PubMed ID: 30325488
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nonviable tumor tissue should not upstage Wilms' tumor from stage I to stage II: a report from the SIOP 93-01 nephroblastoma trial and study.
    Vujanić GM; Harms D; Bohoslavsky R; Leuschner I; de Kraker J; Sandstedt B
    Pediatr Dev Pathol; 2009; 12(2):111-5. PubMed ID: 18811224
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Results of the Third AIEOP Cooperative Protocol on Wilms Tumor (TW2003) and Related Considerations.
    Spreafico F; Biasoni D; Lo Vullo S; Gandola L; D'Angelo P; Terenziani M; Bianchi M; Provenzi M; Indolfi P; Pession A; Nantron M; Di Cataldo A; Morosi C; Perotti D; Catania S; Bellani FF; Collini P;
    J Urol; 2017 Nov; 198(5):1138-1145. PubMed ID: 28655531
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relapse of unilateral favorable histology Wilms' tumor: significant clinicopathological factors.
    Aoba T; Urushihara N; Fukumoto K; Furuta S; Fukuzawa H; Mitsunaga M; Watanabe K; Yamoto M; Miyake H; Koyama M; Iwabuchi H; Koike J; Tatsunami S; Wakisaka M; Kitagawa H
    J Pediatr Surg; 2012 Dec; 47(12):2210-5. PubMed ID: 23217878
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A 23-year experience with malignant renal tumors in infancy and childhood.
    Tröbs RB; Hänsel M; Friedrich T; Bennek J
    Eur J Pediatr Surg; 2001 Apr; 11(2):92-8. PubMed ID: 11371043
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical and biologic significance of nuclear unrest in Wilms tumor.
    Hill DA; Shear TD; Liu T; Billups CA; Singh PK; Dome JS
    Cancer; 2003 May; 97(9):2318-26. PubMed ID: 12712489
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of TCF3 as potential master regulator in blastemal Wilms tumors.
    Kehl T; Schneider L; Kattler K; Stöckel D; Wegert J; Gerstner N; Ludwig N; Distler U; Tenzer S; Gessler M; Walter J; Keller A; Graf N; Meese E; Lenhof HP
    Int J Cancer; 2019 Mar; 144(6):1432-1443. PubMed ID: 30155889
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.